Holdings (as at 2025-09-12)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Insmed Incorporated 3.07%
United Therapeutics Corporation 2.98%
Tempus AI, Inc. (Class A) 2.88%
Elanco Animal Health Incorporated 2.74%
Jazz Pharmaceuticals Plc 2.51%
Biogen Inc. 2.44%
Alnylam Pharmaceuticals, Inc. 2.42%
Zimmer Biomet Holdings, Inc. 2.39%
Regeneron Pharmaceuticals, Inc. 2.26%
Universal Health Services, Inc. (Class B) 2.24%
Merck & Co., Inc. 2.21%
Acadia Healthcare Company, Inc. 2.03%
Johnson & Johnson 1.97%
Avantor, Inc. 1.93%
Cardinal Health, Inc. 1.92%
UnitedHealth Group Incorporated 1.91%
Humana Inc. 1.91%
Exelixis, Inc. 1.88%
Organon & Co. 1.86%
Insulet Corporation 1.84%
HCA Healthcare, Inc. 1.79%
Natera, Inc. 1.69%
Pfizer Inc. 1.67%
Abbott Laboratories 1.66%
BioMarin Pharmaceutical Inc. 1.66%
Boston Scientific Corporation 1.62%
Veeva Systems Inc. (Class A) 1.62%
Incyte Corporation 1.55%
The Cigna Group 1.55%
IDEXX Laboratories, Inc. 1.52%
Doximity, Inc. (Class A) 1.47%
Teleflex Incorporated 1.40%
Tenet Healthcare Corporation 1.39%
Medtronic Plc 1.37%
Elevance Health Inc. 1.36%
ResMed Inc. 1.33%
Gilead Sciences, Inc. 1.31%
GE HealthCare Technologies Inc. 1.31%
Centene Corporation 1.30%
Quest Diagnostics Incorporated 1.29%
Exact Sciences Corporation 1.29%
Royalty Pharma Plc (Class A) 1.28%
Bristol-Myers Squibb Company 1.27%
Corcept Therapeutics Inc. 1.26%
Thermo Fisher Scientific Inc. 1.00%
IQVIA Holdings Inc. 1.00%
Becton, Dickinson and Company 0.92%
Penumbra, Inc. 0.90%
Labcorp Holdings Inc. 0.90%
Encompass Health Corporation 0.87%
Hologic, Inc. 0.84%
Globus Medical, Inc. (Class A) 0.84%
Stryker Corporation 0.82%
Henry Schein, Inc. 0.80%
The Cooper Companies, Inc. 0.79%
Chemed Corporation 0.77%
Molina Healthcare, Inc. 0.77%
Masimo Corporation 0.74%
Revvity, Inc. 0.72%
Intuitive Surgical, Inc. 0.70%
Halozyme Therapeutics, Inc. 0.59%
West Pharmaceutical Services, Inc. 0.46%
Neurocrine Biosciences, Inc. 0.45%
Agilent Technologies, Inc. 0.41%
Steris Plc 0.41%
Amgen Inc. 0.39%
Edwards Lifesciences Corporation 0.39%
Danaher Corporation 0.38%
Zoetis Inc. 0.38%
Solventum Corporation 0.38%
DaVita Inc. 0.37%
DexCom, Inc. 0.35%
Summit Therapeutics Inc. 0.35%
Waters Corporation 0.34%
Perrigo Company Plc 0.33%
Align Technology, Inc. 0.28%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.